Twitter
On the 29th of February, ADAPT SMART hosted an invitation-only multi-stakeholder workshop around selection criteria for MAPPs in Amsterdam, The Netherlands. The programme from the event can be found here. A full report of the event will be available in due course. A preliminary overview of conclusions was prepared for the participants in the “Innovation for the benefit of the patient” conference organized by the Dutch Ministry of Health on 1-2 March 2016. The document can be viewed via IMI ADAPT SMART workshop – Selection Criteria for MAPPs- Exploring and aligning stakeholder needs (Amsterdam, 29 February 2016).
  • Blog From D2.03 Work Package Leaders: A blog co-authored by Angelika Joos (MSD) and Mathieu Boudes (EURORDIS) in their capacity as ADAPT SMART D2.03 leaders also provides reflections on the workshop’s outcomes. The blog can be viewed here.
2018-04-11T14:58:10+00:00

 

This project has received funding from the Innovative Medicines Initiative 2 Joint Undertaking under grant agreement No 115890. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.